During treating HIV/AIDS patients with ARV, along with following up treatment' results, side effects of ARV should be concerned: Some of major side effects are those on liver. Purpose: investigate the changes of liver enzymes, bilirubine levels in HIV/AIDS patients treated with d4T/3TC/NVP regimen. Method: 99 HIV/AIDS patients with normal liver enzymes were treated with d4T/3TC/NVP, the changes of liver enzymes of those patients after treatment were evaluated. Result: 2 weeks and 4 weeks after treatment, ALT level increased in 6,1 percent and 11,1 percent patients respectively
AST level increased in 9,1 percent and 12,1 percent patients respectively
Bilirubine level increased in 5,1 percent patients. Patients suffering serious side effects which led to the change of treatment medication accounted for 4 percent.